RESEARCH LETTER
 
TOPICS
Urology
 
REFERENCES (17)
1.
LeRoith D, Holly JMP, Forbes BE. Insulin-like growth factors: Ligands, binding proteins, and receptors. Mol Metab 2021; 52: 101245.
 
2.
Liu Y, Shen S, Yan Z, et al. Expression characteristics and their functional role of IGFBP gene family in pan-cancer. BMC Cancer 2023; 23: 371.
 
3.
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915-28.
 
4.
Watts EL, Perez-Cornago A, Fensom GK, et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol 2023; 52: 71-86.
 
5.
Rasti A, Khalili M, Yasseri AMF, et al. Evaluation of IGF2, KRT14, and KRT20 as urinary biomarkers in patients with bladder cancer. Rep Biochem Mol Biol 2023; 11: 710-9.
 
6.
Tang J, Zhao C, Lin S, Li X, Zhu B, Li Y. Controversial causal association between IGF family members and osteoporosis: a Mendelian randomization study between UK and FinnGen biobanks. Front Endocrinol (Lausanne) 2024; 14: 1332803.
 
7.
Jiang R, Qu Q, Wang Z, Luo F, Mou S. Association between air pollution and bone mineral density: a Mendelian randomization study. Arch Med Sci 2024; 20: 1334-8.
 
8.
Yavorska OO, Burgess S. Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 2017; 46: 1734-9.
 
9.
Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 2017; 36: 1783-802.
 
10.
Del Greco MF, Minelli C, Sheehan N, Thompson J. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 2015; 34: 2926-40.
 
11.
Eich ML, Tregnago AC, Faraj SF, et al. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma. Virchows Arch 2019; 474: 21-7.
 
12.
Liang PI, Wang YH, Wu TF, et al. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. J Clin Pathol 2013; 66: 573-82.
 
13.
Bei Y, Huang Q, Shen J, et al. IGFBP6 regulates cell apoptosis and migration in glioma. Cell Mol Neurobiol 2017; 37: 889-98.
 
14.
Massoner P, Ladurner Rennau M, Heidegger I, et al. Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF- treatment. Am J Pathol 2011; 179: 2905-19.
 
15.
Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab 1996; 81: 3709-16.
 
16.
Bach LA, Fu P, Yang Z. Insulin-like growth factor-binding protein-6 and cancer. Clin Sci (Lond) 2013; 124: 215-29.
 
17.
Shen YW, Zhou YD, Chen HZ, Luan X, Zhang WD. Targeting CTGF in cancer: an emerging therapeutic opportunity. Trends Cancer 2021; 7: 511-24.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top